🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesSTEP-HFpEF: semaglutide in heart failure with preserved EF — 6 month update Page 3

STEP-HFpEF: semaglutide in heart failure with preserved EF — 6 month update

dave_SLC Mon, Dec 22, 2025 at 4:05 PM 12 replies 1,022 viewsPage 3 of 3
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Dec 23, 2025 at 9:59 AM#11
jim_asheville said:
The mechanism that matters here is not stomach emptying, it is central.

All true, with one condition: that curve is for people who reached the dose on schedule. Anyone who slowed the ladder for tolerability is on a different, flatter curve, and comparing yourself with the published mean will make you feel like a non-responder when you are not.

Last edited: Dec 23, 2025 at 10:59 AM
1 1VendorMark
Reply Quote Save Share Report
NurseAsh_DET
Member
356
1,567
Sep 2024
Detroit, MI
Dec 23, 2025 at 9:21 PM#12
B12Beth said:
Agreed, though "tolerable" needs defining.

This is exactly what I could not find anywhere else.

50 0ricardo_MIA, BrianDallas92, labquiet_amy and 47 others
Reply Quote Save Share Report
SallyK_inj
Member
567
2,345
Jul 2024
Iowa
Dec 24, 2025 at 8:43 AM#13
jim_asheville said:
The mechanism that matters here is not stomach emptying, it is central.

I will push back on the "any working dose is fine" framing. The maintenance evidence sits overwhelmingly at the top studied dose, and the extension data shows regain tracking dose reduction rather than tracking stopping. Holding low is reasonable; pretending it is evidentially equivalent is not.

49 24oliver_london, tane_welly, Dr.PathRoch and 46 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Dec 24, 2025 at 8:06 PM#14
dave_SLC said:
Prescribed on cardiovascular grounds rather than for weight, and almost everything written for patients assumes the opposite.

6 month update on cardiovascular risk: down 63 lbs, off blood pressure meds, A1C normalized. Genuinely life-changing.

48 23ben_calgary, patPC_UT, Dr.DermMIA and 45 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Dec 25, 2025 at 7:29 AM#15

Moderator note: the sourcing question belongs in the vendor section and has been split out. No action needed from anybody.

47 22PurityPaulOR, MaxMetOK, MounjBrad and 44 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register